Autor: |
Nikkola J; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland; Department of Urology, Tampere University Hospital, Tampere, Finland; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. Electronic address: jussi.nikkola@fimnet.fi., Ryyppö L; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland., Vuorinen J; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland., Kallio H; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland., Selin H; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland., Jämsä P; Department of Urology, Tampere University Hospital, Tampere, Finland., Åkerla J; Department of Urology, Tampere University Hospital, Tampere, Finland., Virtanen T; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland., Pekkarinen T; Department of Urology, Tampere University Hospital, Tampere, Finland., Kaipia A; Department of Urology, Tampere University Hospital, Tampere, Finland., Pulkkinen J; Department of Pathology, Fimlab Laboratories, Tampere, Finland., Vandekerkhove G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada., Müller DC; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada., Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada., Black PC; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada., Nykter M; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland., Veitonmäki T; Department of Urology, Tampere University Hospital, Tampere, Finland., Annala M; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland. Electronic address: matti.annala@tuni.fi. |